West Pharmaceutical Services Inc (WST)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

$316.50

Buy

$317.53

arrow-up$0.71 (+0.22%)

Prices updated at 04 Jun 2026, 19:07 EDT
| Prices minimum 15 mins delay
|
Prices in USD

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass ...

Income statement

20242025
2,893m3,074m
999m1,104m
591m636m
20.4220.69
493m494m
744m773m
Sales, General and administrative339m394m
Interest expenses3m500,000
Provision for income taxes108m122m
Operating expenses408m468m
Income before taxes586m601m
Net income available to common shareholders493m494m
6.756.83
Net interest income17m17m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)6.696.79
Free cash flow per share4.34455.2021
Book value/share38.06542.3564
Debt equity ratio0.1060280.093955

Balance sheet

20242025
Current assets1,538m1,978m
Current liabilities550m655m
Total capital2,885m3,379m
Total debt302m321m
Total equity2,682m3,176m
Total non current liabilities--
Loans203m203m
Total assets3,643m4,270m
Total liabilities--
Cash and cash equivalents485m791m
Common stock72m72m

Cash flow

20242025
Cash at beginning of period854m485m
Cash dividends paid-59m-61m
276m469m
Investments (gains) losses-379m-286m
485m791m
Net income--
653m755m
-377m-286m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.